Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Glioblastoma × Ipilimumab × Clear all

Phase

Status

Terminated 4 Active not recruiting 4 Recruiting 3 No longer available 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 114 Carcinoma, Non-Small-Cell Lung 34 Neoplasms 26 Prostatic Neoplasms 18 Neoplasm Metastasis 18 Uveal Melanoma 16 Carcinoma, Renal Cell 15 Lung Neoplasms 14 Pancreatic Neoplasms 12 Diabetes Mellitus, Insulin-Dependent, 12 12 Small Cell Lung Carcinoma 11 Colorectal Neoplasms 10 Carcinoma, Hepatocellular 9 Uterine Cervical Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 8 Breast Neoplasms 8 Sarcoma 7 Carcinoma, Transitional Cell 7 Stomach Neoplasms 6 Mesothelioma 6 Kidney Neoplasms 6 Head and Neck Neoplasms 6 Brain Neoplasms 6 Advanced Cancer 6 Urinary Bladder Neoplasms 5 Recurrence 5 Ovarian Neoplasms 5 Lymphoma, Non-Hodgkin 5 Lymphoma 5 Leukemia, Myeloid, Acute 5

Interventions

Temozolomide 201 Radiotherapy 117 Bevacizumab 93 Radiation 39 Magnetic Resonance Spectroscopy 28 Irinotecan 27 Carmustine 25 Surgical Procedures, Operative 24 Lomustine 21 Erlotinib Hydrochloride 19 Chemotherapy, Adjuvant 18 Carboplatin 17 temsirolimus 13 Drug Therapy 13 O(6)-benzylguanine 12 sargramostim 11 Sirolimus 11 Radiotherapy, Intensity-Modulated 11 Radiotherapy, Conformal 11 Nivolumab 11 Sorafenib 10 Radiosurgery 10 Imatinib Mesylate 10 Everolimus 10 pembrolizumab 9 motexafin gadolinium 9 Vorinostat 9 Thalidomide 8 IL13-PE38 8 Gefitinib 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02017717 2025-04-04

CheckMate 143

Bristol-Myers Squibb

Phase 3 Completed

529 enrolled 28 charts

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡